New-look heart pump implanted for first time | A historic operation | Managing chronic venous disease | Vaccines make an impact

The CorWave technology is unlike other left ventricular assist devices, working in harmony with the patient's heartbeat and making adjustments as needed. 

The historic procedure was performed in Texas on a 45-year-old patient who had been hospitalized for months with advanced heart failure.

"These recommendations will help ensure that patient care remains both consistent and personalized," SCAI President Srihari S. Naidu, MD, explained. 

When doctors are accused of mishandling the heart health of a young athlete, it occasionally ends up being settled in a courtroom. 

Staying vaccinated as recommended by doctors can help patients limit their risk of adverse cardiovascular events, according to a new consensus statement published in European Heart Journal.

The device covers three vessels at once and can be deployed through the patient's TAVR access site. Researchers shared their first-in-human experience in JACC: Case Reports.

The STS Risk Calculator App, available on both iOS and Android devices, gives users improved access to real-time risk assessments.

The group highlighted the proven effectiveness of these drugs, especially semaglutide and tirzepatide, while noting that eligibility, affordability and availability will still play key roles in any treatment decisions. 

Even TAVR patients not treated using transfemoral access can typically go home the very next day.